Medical-device company Invenio Imaging is developing technology that enables surgeons to evaluate tissue biopsies in the operating room, immediately after samples are collected - providing in just three minutes AI-accelerated insights that would otherwise take weeks to obtain from a pathology lab.
In a surgical biopsy, a medical professional removes samples of cells or tissue that pathologists analyze for diseases such as cancer. By delivering these capabilities through a compact, AI-powered imaging system within the treatment room, Invenio aims to support rapid clinical decision-making.
This technology will help surgeons make intraoperative decisions when performing a biopsy or surgery, said Chris Freudiger, chief technology officer of Silicon Valley-based Invenio. They'll be able to rapidly evaluate whether the tissue sample contains cancerous cells, decide whether they need to take another tissue sample and, with the AI models Invenio is developing, potentially make a molecular diagnosis for personalized medical treatment within minutes.
Quicker diagnosis enables quicker treatment. It's especially critical for aggressive types of cancer that could grow or spread significantly in the weeks it takes for biopsy results to return from a dedicated pathology lab.
Invenio is a member of NVIDIA Inception, a program that provides cutting-edge startups with technological support and AI platform guidance. The company accelerates AI training and inference using NVIDIA GPUs and software libraries.
Laser Focus on Cancer Care The NIO Laser Imaging System accelerates the imaging of fresh tissue biopsies. Invenio's NIO Laser Imaging System is a digital pathology tool that accelerates the imaging of fresh tissue biopsies. It's been used in thousands of procedures in the U.S. and Europe. In 2021, it received the CE Mark of regulatory approval in Europe.
The company plans to adopt the NVIDIA Jetson Orin series of edge AI modules for its next-generation imaging system, which will feature near real-time AI inference accelerated by the NVIDIA TensorRT SDK.
We're building a layer of AI models on top of our imaging capabilities to provide physicians with not just the diagnostic image but also an analysis of what they're seeing, Freudiger said. With the AI performance provided by NVIDIA Jetson at the edge, they'll be able to quickly determine what kinds of cancer cells are present in a biopsy image.
Invenio uses a cluster of NVIDIA RTX A6000 GPUs to train neural networks with tens of millions of parameters on pathologist-annotated images. The models were developed using the TensorFlow deep learning framework and trained on images acquired with NIO imaging systems.
The most powerful capability for us is the expanded VRAM on the RTX A6000 GPUs, which allows us to load large batches of images and capture the variability of features, Freudiger said. It makes a big difference for AI training.
On the Path to Clinical Deployment One of Invenio's AI products, NIO Glioma Reveal, is approved for clinical use in Europe and available for research use in the U.S. to help identify areas of cancerous cells in brain tissue.
A team of Invenio's collaborators from the University of Michigan, New York University, University of California San Francisco, the Medical University of Vienna and University Hospital of Cologne recently developed a deep learning model that can find biomarkers of cancerous tumors with 93% accuracy in 90 seconds.
With this ability to analyze different molecular subtypes of cancer within a tissue sample, doctors can predict how well a patient will respond to chemotherapy - or determine whether a tumor has been successfully removed during surgery.
Beyond its work on brain tissue analysis, Invenio this year announced a clinical research collaboration with Johnson & Johnson's Lung Cancer Initiative to develop and validate an AI solution that can help evaluate lung biopsies. The AI model will help doctors rapidly determine whether collected tissue samples contain cancer.
Lung cancer is the world's deadliest form of cancer, and in the U.S. alone, lung nodules are found in over 1.5 million patients each year. Once approved for clinical use, Invenio's NIO Lung Cancer Reveal tool aims to shorten the time needed to analyze tissue biopsies for these patients.
As part of this initiative, Invenio will run a clinical study before submitting the NVIDIA Jetson-powered AI solution for FDA approval.
Subscribe to NVIDIA healthcare news.
Most recent headlines
17/12/2025
eds3_5_jq(document).ready(function($) { $(#eds_sliderM519).chameleonSlider_2_1({...
17/12/2025
Audiences Watched Over 103 Billion Minutes of TV on Thanksgiving Day
NFL Games ...
17/12/2025
Share Share by:
Copy link
Facebook
X
Whatsapp
Pinterest
Flipboard...
17/12/2025
Share Share by:
Copy link
Facebook
X
Whatsapp
Pinterest
Flipboard...
17/12/2025
Share Share by:
Copy link
Facebook
X
Whatsapp
Pinterest
Flipboard...
17/12/2025
Share Share by:
Copy link
Facebook
X
Whatsapp
Pinterest
Flipboard...
17/12/2025
Share Share by:
Copy link
Facebook
X
Whatsapp
Pinterest
Flipboard...
17/12/2025
Share Share by:
Copy link
Facebook
X
Whatsapp
Pinterest
Flipboard...
17/12/2025
Share Share by:
Copy link
Facebook
X
Whatsapp
Pinterest
Flipboard...
17/12/2025
Share Share by:
Copy link
Facebook
X
Whatsapp
Pinterest
Flipboard...
17/12/2025
Share Share by:
Copy link
Facebook
X
Whatsapp
Pinterest
Flipboard...
17/12/2025
Share Share by:
Copy link
Facebook
X
Whatsapp
Pinterest
Flipboard...
17/12/2025
Share Share by:
Copy link
Facebook
X
Whatsapp
Pinterest
Flipboard...
17/12/2025
KPop Demon Hunters Stars Visit Berklee for Weeklong Celebration Andrew Choi and EJAE, who voiced the film's main characters and contributed to its soundtr...
17/12/2025
RT has announced that Kathy Fox has been appointed Commissioning Editor with re...
17/12/2025
The Hao AI Lab research team at the University of California San Diego - at the forefront of pioneering AI model innovation - recently received an NVIDIA DGX B...
17/12/2025
Editor's note: This post is part of Into the Omniverse, a series focused on ...
17/12/2025
With the new season of Dancing with the Stars shimmering in the not-too-distant future this New Year, the celebrity and dancer pairings of the twelve couples ha...
16/12/2025
Hawkins has landed on Spotify, just in time for Stranger Things Season 5, Volume...
16/12/2025
Wherever you are, your favorite music and audio content should go seamlessly with you. That's why Spotify has partnered with NAVER Corp, Korea's leading...
16/12/2025
2025 Wrapped arrived bigger and bolder than ever. This year's experience is designed to be ultra personal and shareable, with new features like Wrapped Part...
16/12/2025
Three 12-kilowatt Advanced Electric Propulsion System thrusters, supplied by L3Harris Technologies, form the core of Gateway's propulsion system. Pictured i...
16/12/2025
The challenge facing America's defense industrial base is not just about speed - its about rebuilding the foundation that makes speed possible. Our nations ...
16/12/2025
Share Share by:
Copy link
Facebook
X
Whatsapp
Pinterest
Flipboard...
16/12/2025
SEVILLE, Spain Canal Sur, the public broadcasting service for Andalusia, Spain, has completed a total technology refresh based on Pebble's resilient, softwa...
16/12/2025
NEW YORK Teleprompting hardware provider Telescript International has acquired all software code and intellectual property previously owned by Telescript West. ...
16/12/2025
As cable operators face increased competition from 5G fixed wireless access providers, a new report from Ookla Research finds that T-Mobile is the FWA speed lea...
16/12/2025
Apple has announced a major upgrade to the Apple TV app for device owners outside the Apple ecosystem with news that the Apple TV app for Android now supports G...
16/12/2025
Space42 grows Direct-to-Device partner ecosystem through a Memorandum of Underst...
16/12/2025
16 Dec 2025
VEON Announces Release Date for Full Year and Fourth Quarter 2025 R...
16/12/2025
16 Dec 2025
VEON's Kyivstar Invests in Renewable Energy in Ukraine with Acq...
16/12/2025
Back to All News
Emma Appleton, Fares Fares, Frida Gustavsson and Jakob Oftebro...
16/12/2025
Back to All News
Docu-reality My Korean Boyfriend Gets a Trailer and Premiere D...
16/12/2025
Harmonic's XOS Advanced Media Processor Improves Streaming Video Quality and Boosts Viewer Engagement SAN JOSE, Calif. - Dec. 16, 2025 - Harmonic (NASDAQ: ...
16/12/2025
RT Sport Awards 2025 live on RT One and RT Player at 8:05pm on Saturday 20 December.
On Saturday 20 December live on RT One and RT Player at the earlier t...
16/12/2025
Singer -songwriter Brian Kennedy has been announced as the final celebrity dance...
15/12/2025
Harlem Globetrotters Celebrate 100th Anniversary With New Brand Campaign From Th...
15/12/2025
Top L-R: La Tierra Del Valor (The Home of the Brave), Mangittatuarjuk (The Gnawe...
15/12/2025
L3Harris will leverage 15 years of experience supporting the E-4B Nightwatch and...
15/12/2025
CONWAY, Ark. In a notable example of how the loss of federal funding is forcing public stations to make massive cuts and operational changes, the statewide pub...
15/12/2025
BOULDER, Colo. Public Media Venture Group (PMVG), Venture Technologies Group (VTG), and WQED have completed a multipart agreement that they say will significant...
15/12/2025
Cape Town, November 13, 2025 - SES and International artist and humanitarian, Fo...
15/12/2025
Luxembourg, December 15, 2025 - SES, a leading space solutions company, and Abra Group launched fast and reliable multi-orbit inflight connectivity service on t...
15/12/2025
How Rivian s Design Puts Drivers First-And Why That Matters Published on Dec 15, 2025 Categories: Business Solutions
LinkedIn Corporate Communications
Sha...
15/12/2025
Space42 and Cobham Satcom completed the full range of advanced terminals for the...
15/12/2025
15 Dec 2025
VEON's Beeline Kazakhstan Delivers First Starlink Direct to Cel...
15/12/2025
Andrew Mountbatten-Windsor finds himself the topic of year's cracker jokes
Oasis, David Harbour, Celebrity Traitors and Angela Rayner all feature in this y...
15/12/2025
Comscore Expands Cross-Platform Campaign Measurement to Include Audio and Social New capabilities strengthen cross-platform campaign reporting suite; CCR rebran...
15/12/2025
NVIDIA today announced it has acquired SchedMD - the leading developer of Slurm, an open-source workload management system for high-performance computing (HPC) ...
Medical-device company Invenio Imaging is developing technology that enables surgeons to evaluate tissue biopsies in the operating room, immediately after samples are collected - providing in just three minutes AI-accelerated insights that would otherwise take weeks to obtain from a pathology lab.
